Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
2226
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.9M | ﹤0.01% |
33,944
-103
| -0.3% | -$10.2K |
|
2227
Harmonic Inc
HLIT
$1.24B
| $2.89M | ﹤0.01% |
521,269
+20,100
| +4% | +$111K |
|
2228
Constellium
CSTM
$4.05B
| $2.89M | ﹤0.01% |
287,998
+15,366
| +6% | +$142K |
|
2229
Monarch Casino & Resort
MCRI
$2.19B
| $2.88M | ﹤0.01% |
67,459
+1,386
| +2% | +$60.6K |
|
|
HONE
2230
DELISTED
HarborOne Bancorp
HONE
| $2.88M | ﹤0.01% |
275,766
+3,254
| +1% | +$32.9K |
|
2231
Innovative Industrial Properties
IIPR
$1.67B
| $2.87M | ﹤0.01% |
23,258
+1,004
| +5% | +$92.1K |
|
2232
Collegium Pharmaceutical
COLL
$843M
| $2.87M | ﹤0.01% |
217,798
+49,860
| +30% | +$667K |
|
2233
Forrester Research
FORR
$225M
| $2.85M | ﹤0.01% |
60,672
+1,734
| +3% | +$83.5K |
|
|
WSR
2234
DELISTED
Whitestone REIT
WSR
| $2.85M | ﹤0.01% |
224,645
+4,923
| +2% | +$61.7K |
|
2235
Q32 Bio
QTTB
$459M
| $2.85M | ﹤0.01% |
8,093
+4,258
| +111% | +$1.67M |
|
|
ALLK
2236
DELISTED
Allakos
ALLK
| $2.85M | ﹤0.01% |
65,753
+9,825
| +18% | +$403K |
|
2237
Ezcorp Inc
EZPW
$1.66B
| $2.85M | ﹤0.01% |
300,661
-954
| -0.3% | -$9.29K |
|
2238
NovaGold Resources
NG
$3.37B
| $2.85M | ﹤0.01% |
+481,649
| New | +$2.06M |
|
2239
Rhythm Pharmaceuticals
RYTM
$7.77B
| $2.82M | ﹤0.01% |
128,339
+18,917
| +17% | +$478K |
|
2240
The Bancorp
TBBK
$2.83B
| $2.82M | ﹤0.01% |
316,276
+7,713
| +2% | +$71K |
|
2241
Pinduoduo
PDD
$129B
| $2.82M | ﹤0.01% |
136,500
+3,540
| +3% | +$76.6K |
|
|
CBAY
2242
DELISTED
Cymabay Therapeutics
CBAY
| $2.81M | ﹤0.01% |
393,123
+28,205
| +8% | +$319K |
|
|
ALTA
2243
DELISTED
Altabancorp
ALTA
| $2.81M | ﹤0.01% |
95,633
+4,396
| +5% | +$126K |
|
|
RYZ
2244
Ryerson Holding Corp
RYZ
$1.44B
| $2.81M | ﹤0.01% |
337,035
+42,623
| +14% | +$375K |
|
|
COWN
2245
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.8M | ﹤0.01% |
162,866
+3,484
| +2% | +$56.3K |
|
2246
First Community Bankshares
FCBC
$918M
| $2.8M | ﹤0.01% |
82,897
+582
| +0.7% | +$19.6K |
|
2247
Arrow Financial
AROW
$721M
| $2.8M | ﹤0.01% |
93,319
+1,686
| +2% | +$48.7K |
|
|
IVC
2248
DELISTED
Invacare Corporation
IVC
| $2.79M | ﹤0.01% |
538,403
+16,014
| +3% | +$104K |
|
|
BAND
2249
Bandwidth Inc
BAND
$1.66B
| $2.79M | ﹤0.01% |
+37,168
| New | +$2.71M |
|
|
EFC
2250
Ellington Financial
EFC
$1.75B
| $2.79M | ﹤0.01% |
+155,133
| New | +$2.8M |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.